Theseus Pharmaceuticals, Inc.
NASDAQ:THRX
4.065 (USD) • At close February 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -50.608 | -27.308 | -11.997 | -7.183 |
| Depreciation & Amortization
| 0.05 | 0.002 | 0.002 | 0.002 |
| Deferred Income Tax
| 0 | -4.361 | 0 | 0 |
| Stock Based Compensation
| 11.412 | 4.361 | 1.052 | 0.317 |
| Change In Working Capital
| 6.551 | -4.248 | 0.933 | -0.179 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 3.971 | -0.15 | 0.849 | 0.193 |
| Other Working Capital
| 2.58 | -4.098 | 0.084 | -0.372 |
| Other Non Cash Items
| -0.35 | 4.361 | 5.158 | 2.236 |
| Operating Cash Flow
| -32.945 | -27.193 | -4.852 | -4.807 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.455 | 0.012 | 0 | 0 |
| Acquisitions Net
| 0.117 | 0 | 0 | 0 |
| Purchases Of Investments
| -191.439 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 74.6 | 0 | 0 | 0 |
| Other Investing Activites
| -0.117 | 0 | 0 | 0 |
| Investing Cash Flow
| -117.294 | 0.012 | 0 | 0 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 166.242 | 11.992 | 2.993 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 97.535 | 0 | 0 |
| Financing Cash Flow
| 0 | 263.777 | 11.992 | 2.993 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | -0.012 | 0 | 0 |
| Net Change In Cash
| -150.057 | 236.584 | 7.14 | -1.814 |
| Cash At End Of Period
| 94.984 | 245.041 | 8.457 | 1.317 |